Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: Executive summary-a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
European Heart Journal, ISSN: 0195-668X, Vol: 31, Issue: 11, Page: 1311-1318
2010
- 253Citations
- 158Captures
- 2Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations253
- Citation Indexes229
- 229
- CrossRef153
- Clinical Citations16
- PubMed Guidelines16
- Policy Citations8
- Policy Citation8
- Captures158
- Readers158
- 158
- Mentions2
- News Mentions2
- News2
Most Recent News
Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control
STUDY INFORMATION OFFICIAL TITLE: Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control CURRENT STATUS: Recruiting STUDY TYPE: Interventional SPONSOR AGENCY:CAMC Health SystemCLASS:Other
Review Description
There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis and the risk of bleeding. The full consensus document comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients. This executive summary highlights the main recommendations from the consensus document. © The Author 2010.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=77953189870&origin=inward; http://dx.doi.org/10.1093/eurheartj/ehq117; http://www.ncbi.nlm.nih.gov/pubmed/20447945; https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehq117; https://dx.doi.org/10.1093/eurheartj/ehq117; https://academic.oup.com/eurheartj/article/31/11/1311/590764
Oxford University Press (OUP)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know